Plasmonic Nanotheranostics: Merging Imaging and Therapy on a Unified Platform for Precision Oncology
ACS Applied Bio Materials · 2026
DOI: 10.1021/acsabm.5c02583 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Yuan-Fong Chou Chau. Beteiligte Einrichtung: Centre for Advanced Material and Energy Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong BE1410, Brunei Darussalam. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Neoplasms, Biocompatible Materials, Precision Medicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 170 Literaturangaben. Gefördert von: Universiti Brunei Darussalam.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Advanced Material and Energy Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong BE1410, Brunei Darussalam.
Förderung
- Universiti Brunei Darussalam
Zitieren
APA
Chou Chau, Y. F. (2026). Plasmonic Nanotheranostics: Merging Imaging and Therapy on a Unified Platform for Precision Oncology. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c02583
Vancouver
Chou Chau YF. Plasmonic Nanotheranostics: Merging Imaging and Therapy on a Unified Platform for Precision Oncology. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.5c02583
BibTeX
@article{ChouChau2026,
author = {Chou Chau, Yuan-Fong},
title = {Plasmonic Nanotheranostics: Merging Imaging and Therapy on a Unified Platform for Precision Oncology},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.5c02583}
}
EUVIMED